Skip to content

Inogen INGN Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

ResMed logo
ResMedRMD
AdaptHealth logo
AdaptHealthAHCO
Pulmonx Corporation logo
Pulmonx CorporationLUNG
Savara logo
SavaraSVRA
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's software and technology licenses, net?
Inogen (INGN) reported software and technology licenses, net of $6.45M in Q1 2026.
How has Inogen's software and technology licenses, net changed year-over-year?
Inogen's software and technology licenses, net decreased by 8.0% year-over-year, from $7.02M to $6.45M.
What is the long-term trend for Inogen's software and technology licenses, net?
Over 5 years (2020 to 2025), Inogen's software and technology licenses, net has grown at a 17.6% compound annual growth rate (CAGR), from $2.67M to $6M.